Screener
CorMedix CRMD Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: CorMedix’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
| Line item | For the Three Months Ended March 31, 2026 | For the Three Months Ended March 31, 2025 |
|---|---|---|
| Increase in accounts payable | 4,943 | 213 |
| (Decrease) increase in accrued expenses and other liabilities | (50,622) | 292 |
| Payment of contingent consideration liabilities | (220) | - |
| Net cash provided by operating activities | 42,382 | 19,737 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Purchase of short-term investments | - | (9,985) |
| Maturity of short-term investments | 3,694 | 9,800 |
| Purchase of equipment | (729) | (10) |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is CorMedix's operating cash flow?
- CorMedix (CRMD) reported operating cash flow of $42.38M in Q1 2026.
- How has CorMedix's operating cash flow changed year-over-year?
- CorMedix's operating cash flow increased by 114.7% year-over-year, from $19.74M to $42.38M.
- What is the long-term trend for CorMedix's operating cash flow?
- Over 4 years (2021 to 2025), CorMedix's operating cash flow has grown at a 69.6% compound annual growth rate (CAGR), from -$21.16M to $175.05M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about CorMedix's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude